+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Viral Vectors Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • August 2022
  • Region: Global
  • TechNavio
  • ID: 4860971
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The viral vectors market is poised to grow by $490.64 mn during 2022-2026, accelerating at a CAGR of 14.23% during the forecast period. The report on the viral vectors market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases, increasing use of viral vectors to develop gene therapies and vaccines and growing funding for and investments in gene therapies and vaccines.

The viral vectors market analysis includes the application segment and geographic landscape.

The viral vectors market is segmented as below:

By Application

  • Gene therapy
  • Vaccines

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing number of R&D activities for the development of gene therapies and vaccines using viral vectors as one of the prime reasons driving the viral vector market growth during the next few years. Also, the rising number of M&A and collaborations and the emergence of novel technologies to manufacture viral vectors will lead to sizable demand in the market.

The report on the viral vectors market covers the following areas:

  • Viral vectors market sizing
  • Viral vectors market forecast
  • Viral vectors market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading viral vectors market vendors that include Batavia Biosciences BV, Bayer AG, Catalent Inc., Creative Biogene, Danaher Corp., F. Hoffmann La Roche Ltd., FinVector Oy, Freeline Therapeutics Holdings plc, FUJIFILM Holdings Corp, Institut Merieux, Lonza Group Ltd., Merck KGaA, Novartis AG, Oxford Biomedica Plc, REGENXBIO Inc, Sirion Biotech GmbH, Takara Holdings Inc, Thermo Fisher Scientific Inc., uniQure NV, and Virovek Inc. Also, the viral vectors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Application
5.1 Market segments
Exhibit 24: Chart on Application - Market share 2021-2026 (%)
Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
5.2 Comparison by Application
Exhibit 26: Chart on Comparison by Application
Exhibit 27: Data Table on Comparison by Application
5.3 Gene therapy - Market size and forecast 2021-2026
Exhibit 28: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
5.4 Vaccines - Market size and forecast 2021-2026
Exhibit 32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Application
Exhibit 36: Market opportunity by Application ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 UK - Market size and forecast 2021-2026
Exhibit 62: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Batavia Biosciences BV
Exhibit 85: Batavia Biosciences BV - Overview
Exhibit 86: Batavia Biosciences BV - Product/Service
Exhibit 87: Batavia Biosciences BV - Key offerings
10.4 Bayer AG
Exhibit 88: Bayer AG - Overview
Exhibit 89: Bayer AG - Business segments
Exhibit 90: Bayer AG - Key offerings
Exhibit 91: Bayer AG - Segment focus
10.5 Creative Biogene
Exhibit 92: Creative Biogene - Overview
Exhibit 93: Creative Biogene - Product/Service
Exhibit 94: Creative Biogene - Key offerings
10.6 F. Hoffmann La Roche Ltd.
Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus
10.7 FinVector Oy
Exhibit 100: FinVector Oy - Overview
Exhibit 101: FinVector Oy - Product/Service
Exhibit 102: FinVector Oy - Key offerings
10.8 FUJIFILM Holdings Corp
Exhibit 103: FUJIFILM Holdings Corp - Overview
Exhibit 104: FUJIFILM Holdings Corp - Business segments
Exhibit 105: FUJIFILM Holdings Corp - Key offerings
Exhibit 106: FUJIFILM Holdings Corp - Segment focus
10.9 Lonza Group Ltd.
Exhibit 107: Lonza Group Ltd. - Overview
Exhibit 108: Lonza Group Ltd. - Business segments
Exhibit 109: Lonza Group Ltd. - Key news
Exhibit 110: Lonza Group Ltd. - Key offerings
Exhibit 111: Lonza Group Ltd. - Segment focus
10.10 Merck KGaA
Exhibit 112: Merck KGaA - Overview
Exhibit 113: Merck KGaA - Business segments
Exhibit 114: Merck KGaA - Key news
Exhibit 115: Merck KGaA - Key offerings
Exhibit 116: Merck KGaA - Segment focus
10.11 Oxford Biomedica Plc
Exhibit 117: Oxford Biomedica Plc - Overview
Exhibit 118: Oxford Biomedica Plc - Business segments
Exhibit 119: Oxford Biomedica Plc - Key offerings
Exhibit 120: Oxford Biomedica Plc - Segment focus
10.12 Thermo Fisher Scientific Inc.
Exhibit 121: Thermo Fisher Scientific Inc. - Overview
Exhibit 122: Thermo Fisher Scientific Inc. - Business segments
Exhibit 123: Thermo Fisher Scientific Inc. - Key news
Exhibit 124: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 125: Thermo Fisher Scientific Inc. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 126: Inclusions checklist
Exhibit 127: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 128: Currency conversion rates for US$
11.4 Research methodology
Exhibit 129: Research methodology
Exhibit 130: Validation techniques employed for market sizing
Exhibit 131: Information sources
11.5 List of abbreviations
Exhibit 132: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Application - Market share 2021-2026 (%)
Exhibits 25: Data Table on Application - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Application
Exhibits 27: Data Table on Comparison by Application
Exhibits 28: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Vaccines - Year-over-year growth 2021-2026 (%)
Exhibits 36: Market opportunity by Application ($ million)
Exhibits 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 40: Chart on Geographic comparison
Exhibits 41: Data Table on Geographic comparison
Exhibits 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 78: Market opportunity By Geographical Landscape ($ million)
Exhibits 79: Impact of drivers and challenges in 2021 and 2026
Exhibits 80: Overview on Criticality of inputs and Factors of differentiation
Exhibits 81: Overview on factors of disruption
Exhibits 82: Impact of key risks on business
Exhibits 83: Vendors covered
Exhibits 84: Matrix on vendor position and classification
Exhibits 85: Batavia Biosciences BV - Overview
Exhibits 86: Batavia Biosciences BV - Product/Service
Exhibits 87: Batavia Biosciences BV - Key offerings
Exhibits 88: Bayer AG - Overview
Exhibits 89: Bayer AG - Business segments
Exhibits 90: Bayer AG - Key offerings
Exhibits 91: Bayer AG - Segment focus
Exhibits 92: Creative Biogene - Overview
Exhibits 93: Creative Biogene - Product/Service
Exhibits 94: Creative Biogene - Key offerings
Exhibits 95: F. Hoffmann La Roche Ltd. - Overview
Exhibits 96: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 97: F. Hoffmann La Roche Ltd. - Key news
Exhibits 98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 99: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 100: FinVector Oy - Overview
Exhibits 101: FinVector Oy - Product/Service
Exhibits 102: FinVector Oy - Key offerings
Exhibits 103: FUJIFILM Holdings Corp - Overview
Exhibits 104: FUJIFILM Holdings Corp - Business segments
Exhibits 105: FUJIFILM Holdings Corp - Key offerings
Exhibits 106: FUJIFILM Holdings Corp - Segment focus
Exhibits 107: Lonza Group Ltd. - Overview
Exhibits 108: Lonza Group Ltd. - Business segments
Exhibits 109: Lonza Group Ltd. - Key news
Exhibits 110: Lonza Group Ltd. - Key offerings
Exhibits 111: Lonza Group Ltd. - Segment focus
Exhibits 112: Merck KGaA - Overview
Exhibits 113: Merck KGaA - Business segments
Exhibits 114: Merck KGaA - Key news
Exhibits 115: Merck KGaA - Key offerings
Exhibits 116: Merck KGaA - Segment focus
Exhibits 117: Oxford Biomedica Plc - Overview
Exhibits 118: Oxford Biomedica Plc - Business segments
Exhibits 119: Oxford Biomedica Plc - Key offerings
Exhibits 120: Oxford Biomedica Plc - Segment focus
Exhibits 121: Thermo Fisher Scientific Inc. - Overview
Exhibits 122: Thermo Fisher Scientific Inc. - Business segments
Exhibits 123: Thermo Fisher Scientific Inc. - Key news
Exhibits 124: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 125: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 126: Inclusions checklist
Exhibits 127: Exclusions checklist
Exhibits 128: Currency conversion rates for US$
Exhibits 129: Research methodology
Exhibits 130: Validation techniques employed for market sizing
Exhibits 131: Information sources
Exhibits 132: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global viral vectors market: Batavia Biosciences BV, Bayer AG, Catalent Inc., Creative Biogene, Danaher Corp., F. Hoffmann La Roche Ltd., FinVector Oy, Freeline Therapeutics Holdings plc, FUJIFILM Holdings Corp, Institut Merieux, Lonza Group Ltd., Merck KGaA, Novartis AG, Oxford Biomedica Plc, REGENXBIO Inc, Sirion Biotech GmbH, Takara Holdings Inc, Thermo Fisher Scientific Inc., uniQure NV, and Virovek Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing number of r and d activities for the development of gene therapies and vaccines using viral vectors.`

According to the report, one of the major drivers for this market is the rising prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Batavia Biosciences BV
  • Bayer AG
  • Catalent Inc.
  • Creative Biogene
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • FinVector Oy
  • Freeline Therapeutics Holdings plc
  • FUJIFILM Holdings Corp
  • Institut Merieux
  • Lonza Group Ltd.
  • Merck KGaA
  • Novartis AG
  • Oxford Biomedica Plc
  • REGENXBIO Inc
  • Sirion Biotech GmbH
  • Takara Holdings Inc
  • Thermo Fisher Scientific Inc.
  • uniQure NV
  • Virovek Inc